Top Story

BLOG: What’s ahead in 2019

December 14, 2018

Implandata begins trial of continual IOP monitoring sensor

December 4, 2018
Implandata Ophthalmic Products has begun a clinical study of its novel pressure sensor for continual monitoring of IOP in glaucoma, according to a press release. The…

ROCK inhibitor represents ‘breakthrough’ treatment with disease-modifying potential

Ocular Surgery News U.S. Edition, December 10, 2018
A new once-a-day eye drop that works differently from other glaucoma drugs is opening a new horizon in treatment of the disease. “For the first time, we have a…

Top five AAO videos

November 30, 2018
At the annual American Academy of Ophthalmology meeting in Chicago, talked with key opinion leaders regarding important ophthalmic advances of the past…
More Headlines »
Clinical Science

Multifocal Visual Evoked Potentials for Early Glaucoma Detection

Ophthalmic Surgery, Lasers and Imaging Retina, July 2012, Volume 43 Issue 4
To compare multifocal visual evoked potentials (mfVEP) with other detection methods in early open-angle glaucoma. Ten…
More »

Surgical Glaucoma Update

This activity is supported by educational grants from Aerie Pharmaceuticals, Inc.; Alcon Laboratories, Inc.; Bausch + Lomb; Glaukos Corporation; and Novartis Pharmaceuticals Corporation.

Incisional glaucoma surgery has traditionally been reserved for patients with progressive disease, and in whom medical…
More »
Meeting News

VIDEO: Canal-based glaucoma surgery

June 23, 2018
More »